Evaluating the Cytotoxic and Metastatic Actions of Cannabinol on HCT-116 Colon Cancer Cells

Gamze Turna Saltoğlu; Serap Yalcin; Bayram Furkan Coşkun; Habibe Sema Arslan

Makale detayları

Evaluating the Cytotoxic and Metastatic Actions of Cannabinol on HCT-116 Colon Cancer Cells

Yazarlar:

Gamze Turna Saltoğlu | Serap Yalcin | Bayram Furkan Coşkun | Habibe Sema Arslan

Yayıncı:

Eskişehir Osmangazi University

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Osmangazi Tıp Dergisi Vol.47 Issue 4, pp.593-599

Belge Tipi:

Makale

Yayın Tarihi:

6/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001343016

pISSN:

1305-4953

Anahtar kelimeler:

Özet:

 It aims to evaluate the cytotoxic and metastatic effects of cannabinol CBN on HCT-116 colon cancer cells. Colorectal cancer is one of the leading causes of cancer-related mortality worldwide, with high recurrence and metastasis rates despite current treatment approaches. In recent years, the antitumor potential of cannabinoids has gained attention; however, the specific effects of CBN remain largely unexplored. HCT-116 colon cancer cells were cultured under laboratory conditions and treated with CBN. Cell viability was assessed using the XTT cytotoxicity assay, while cell migration and invasion capabilities were analyzed through the wound healing assay and invasion assay, respectively. The acquired data were quantified using ImageJ software and statistically evaluated with GraphPad Prism 8. The IC₅₀ value of CBN was determined to be 69.14 μM, and CBN treatment was found to significantly reduce cell viability p0.05. Wound healing assay results demonstrated that CBN treatment markedly inhibited cell migration p0.05. Invasion analyses revealed that CBN significantly reduced invasiveness and provided a notable inhibition compared to the control group p0.05. This provides significant evidence that CBN suppresses metastatic processes in HCT-116 cells. This study supports the potential of CBN as an inhibitor of cytotoxic and metastatic activity in colon cancer cells. The findings indicate that CBN reduces cell proliferation, migration, and invasion, suggesting its potential as a therapeutic agent in colorectal cancer treatment. However, further research is needed to elucidate the underlying molecular mechanisms and validate these effects in in vivo models.

 It aims to evaluate the cytotoxic and metastatic effects of cannabinol CBN on HCT-116 colon cancer cells. Colorectal cancer is one of the leading causes of cancer-related mortality worldwide, with high recurrence and metastasis rates despite current treatment approaches. In recent years, the antitumor potential of cannabinoids has gained attention; however, the specific effects of CBN remain largely unexplored. HCT-116 colon cancer cells were cultured under laboratory conditions and treated with CBN. Cell viability was assessed using the XTT cytotoxicity assay, while cell migration and invasion capabilities were analyzed through the wound healing assay and invasion assay, respectively. The acquired data were quantified using ImageJ software and statistically evaluated with GraphPad Prism 8. The IC₅₀ value of CBN was determined to be 69.14 μM, and CBN treatment was found to significantly reduce cell viability p0.05. Wound healing assay results demonstrated that CBN treatment markedly inhibited cell migration p0.05. Invasion analyses revealed that CBN significantly reduced invasiveness and provided a notable inhibition compared to the control group p0.05. This provides significant evidence that CBN suppresses metastatic processes in HCT-116 cells. This study supports the potential of CBN as an inhibitor of cytotoxic and metastatic activity in colon cancer cells. The findings indicate that CBN reduces cell proliferation, migration, and invasion, suggesting its potential as a therapeutic agent in colorectal cancer treatment. However, further research is needed to elucidate the underlying molecular mechanisms and validate these effects in in vivo models.

 It aims to evaluate the cytotoxic and metastatic effects of cannabinol CBN on HCT-116 colon cancer cells. Colorectal cancer is one of the leading causes of cancer-related mortality worldwide, with high recurrence and metastasis rates despite current treatment approaches. In recent years, the antitumor potential of cannabinoids has gained attention; however, the specific effects of CBN remain largely unexplored. HCT-116 colon cancer cells were cultured under laboratory conditions and treated with CBN. Cell viability was assessed using the XTT cytotoxicity assay, while cell migration and invasion capabilities were analyzed through the wound healing assay and invasion assay, respectively. The acquired data were quantified using ImageJ software and statistically evaluated with GraphPad Prism 8. The IC₅₀ value of CBN was determined to be 69.14 μM, and CBN treatment was found to significantly reduce cell viability p0.05. Wound healing assay results demonstrated that CBN treatment markedly inhibited cell migration p0.05. Invasion analyses revealed that CBN significantly reduced invasiveness and provided a notable inhibition compared to the control group p0.05. This provides significant evidence that CBN suppresses metastatic processes in HCT-116 cells. This study supports the potential of CBN as an inhibitor of cytotoxic and metastatic activity in colon cancer cells. The findings indicate that CBN reduces cell proliferation, migration, and invasion, suggesting its potential as a therapeutic agent in colorectal cancer treatment. However, further research is needed to elucidate the underlying molecular mechanisms and validate these effects in in vivo models.

 Kannabinolün CBN HCT-116 kolon kanseri hücreleri üzerindeki sitotoksik ve metastatik etkilerini değerlendirmeyi amaçlamaktadır. Kolorektal kanser dünya genelinde kanserle ilişkili ölümlerin en yaygın nedenlerinden biridir ve mevcut tedavi yaklaşımlarına rağmen yüksek nüks ve metastaz oranları görülmektedir. Son yıllarda, kannabinoidlerin antitümöral potansiyeli araştırılmakta olup, CBNnin bu konudaki etkileri henüz tam olarak aydınlatılmamıştır. HCT-116 kolon kanseri hücreleri laboratuvar koşullarında kültüre edilerek CBN ile muamele edildi. Hücre canlılığı XTT sitotoksisite testi ile,hücre göçü ve invazyon yeteneği sırasıyla yara iyileşme testi wound healing assay ve invazyon analizi ile değerlendirildi. Elde edilen veriler, ImageJ yazılımı ile sayısallaştırıldı ve GraphPad Prism 8 programı kullanılarak istatistiksel olarak değerlendirildi. CBNnin IC₅₀ değeri 69.14 μM olarak belirlendi ve CBN uygulamasının hücre canlılığında anlamlı bir azalmaya neden olduğu belirlendi. p0.05. Yara iyileşme testi sonuçları, CBN uygulamasının hücre migrasyonunu belirgin şekilde inhibe ettiğini ortaya koymuştur p0.05. İnvazyon analizleri, CBNnin invaziviteyi belirgin derecede azalttığını ve kontrol grubuna kıyasla anlamlı bir inhibisyon sağladığını göstermektedir p0.05. Bu bulgular, CBNnin HCT-116 hücrelerinde metastatik süreçleri baskıladığına dair önemli kanıtlar sunmaktadır. Bu çalışma CBNnin kolon kanseri hücreleri üzerinde sitotoksik ve metastatik aktiviteyi inhibe edici potansiyelini desteklemektedir. Bulgular, CBNnin hücre proliferasyonunu, migrasyonunu ve invazyonunu azalttığını göstermekte olup, kolorektal kanser tedavisinde CBNnin olası terapötik bir ajan olarak değerlendirilebileceğini düşündürmektedir. Ancak, bu etkinin altta yatan moleküler mekanizmalarının daha ayrıntılı olarak araştırılması ve in vivo modellerde test edilmesi gerekmektedir.

Makale detayları

Evaluating the Cytotoxic and Metastatic Actions of Cannabinol on HCT-116 Colon Cancer Cells

Yazarlar:

Gamze Turna Saltoğlu | Serap Yalcin | Bayram Furkan Coşkun | Habibe Sema Arslan

Yayıncı:

Eskişehir Osmangazi University

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Osmangazi Tıp Dergisi Vol.47 Issue 4, pp.593-599

Belge Tipi:

Makale

Yayın Tarihi:

6/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001343016

pISSN:

1305-4953

Colon cancer

Cannabinol

Cytotoxicity

Migration

Invasion

Anticancer agents.Kolon kanseri

Kannabinol

Sitotoksisite

Migrasyon

İnvazyon

Antikanser ajanlar.

Sayı

Makale detayları

Yazarlar: Gamze Turna Saltoğlu | Serap Yalcin | Bayram Furkan Coşkun | Habibe Sema Arslan

Yayıncı: Eskişehir Osmangazi University

Ana Başlıklar: Klinik Tıp Bilimleri (Diğer)

Dergi: Osmangazi Tıp Dergisi Vol.47 Issue 4, pp.593-599

Belge Tipi: Makale

Yayın Tarihi: 6/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001343016

pISSN: 1305-4953

Sayı

Yazarlar:

Gamze Turna Saltoğlu | Serap Yalcin | Bayram Furkan Coşkun | Habibe Sema Arslan

Yayıncı:

Eskişehir Osmangazi University

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Osmangazi Tıp Dergisi Vol.47 Issue 4, pp.593-599

Belge Tipi:

Makale

Yayın Tarihi:

6/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001343016

pISSN:

1305-4953